Cite
HARVARD Citation
Ge, J. et al. (2021). Efficacy and safety of Shexiang Baoxin pill (MUSKARDIA) in patients with stable coronary artery disease: a multicenter, double-blind, placebo-controlled phase IV randomized clinical trial. Chinese medical journal. 134 (2), pp. 185-192. [Online].